Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Fosun, Daiichi Sankyo Ink Deals for Kite's CAR T-Cell Therapy in China and Japan

Kite Pharma has negotiated separate agreements with Fosun Pharma and with Daiichi Sankyo for the development of its lead ...

Forward this item to a colleague:


(Separate multiple addresses by commas)